1. Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. Issue 2 (26th September 2017) Authors: Keystone, Edward C; Breedveld, Ferdinand C; Heijde, Désirée van der; van Vollenhoven, Ronald F; Emery, Paul; Smolen, Josef S; Sainsbury, Iain; Florentinus, Stefan; Kupper, Hartmut; Chen, Kun; Kavanaugh, Arthur Journal: RMD open Issue: Volume 3:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Issue 11 (10th August 2017) Authors: Keystone, Edward C; Taylor, Peter C; Tanaka, Yoshiya; Gaich, Carol; DeLozier, Amy M; Dudek, Anna; Zamora, Jorge Velasco; Cobos, Jose Arturo Covarrubias; Rooney, Terence; Bono, Stephanie de; Arora, Vipin; Linetzky, Bruno; Weinblatt, Michael E Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 11(2017) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗